EP3416627
ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA
:
EP einkaleyfi: Þýðing ekki lögð inn:
25.4.2018:
27.11.2019:
18718476.7
:
24.4.2038
:
ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA
25.4.2018
27.11.2019
:
Sandoz AG:
Lichtstrasse 35, 4056, Basel, CH
:
SCHWARZ, Franz Xaver:
Kundl, AT
:
17168281:
26.4.2017:
EP
:
EP2018060547:
25.4.2018
:
A61K 9/20, A61K 31/437